GULLIVER BIOMED BV

Gulliver Biomed bv develops a nanobody portfolio whilst generating custom nanobodies for the research community and private industry. Camelid nanobodies are the antigen binding part of heavy chain only antibodies. They are exquisite research tools in biomedicine, but can also develop into diagnostics and theraeutics. Gulliver Biomed bv produces the antigen and also isolates nanobodies from large cDNA libraries. This can be further extended to affinity determination and purification of recombinant nanobodies. We provide all information to allow customers becoming acquainted with the technology and putting their nanobodies to good use.